A new trading day began on Tuesday, with Edgewise Therapeutics Inc (NASDAQ: EWTX) stock price down -4.89% from the previous day of trading, before settling in for the closing price of $23.94. EWTX’s price has ranged from $10.60 to $35.50 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -49.00% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -10.06%. With a float of $76.46 million, this company’s outstanding shares have now reached $105.76 million.
In an organization with 110 employees, it is important to assess its efficiency.
Edgewise Therapeutics Inc (EWTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Edgewise Therapeutics Inc is 27.78%, while institutional ownership is 79.02%. The most recent insider transaction that took place on Nov 17 ’25, was worth 1,566,586. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Scientific Officer sold 100,000 for $21.12, making the entire transaction worth $2,112,450. This insider now owns 23,400 shares in total.
Edgewise Therapeutics Inc (EWTX) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.42 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.58% during the next five years compared to -49.00% drop over the previous five years of trading.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Here are Edgewise Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 26.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.08 million. That was better than the volume of 1.18 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.92%.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 74.79%, which indicates a significant increase from 6.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.39 in the past 14 days, which was higher than the 1.02 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.68, while its 200-day Moving Average is $16.74. However, in the short run, Edgewise Therapeutics Inc’s stock first resistance to watch stands at $23.87. Second resistance stands at $24.97. The third major resistance level sits at $25.63. If the price goes on to break the first support level at $22.11, it is likely to go to the next support level at $21.45. The third support level lies at $20.35 if the price breaches the second support level.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
With a market capitalization of 2.41 billion, the company has a total of 105,868K Shares Outstanding. Currently, annual sales are 0 K while annual income is -133,810 K. The company’s previous quarter sales were 0 K while its latest quarter income was -40,670 K.
